WPRIM Management System> DCMS> Acta Pharmaceutica Sinica> 2019> 54> 10

Volume: 54 Issue: 10

1. The roles of m6A in cancer biology and its targeted therapy Page:1771—1782
2. Mechanisms of metabolite-triggered oncogenic signaling in cancer Page:1755—1770
3. Advances of microenvironment-activated nanosized drug delivery system for cancer immunotherapy Page:1802—1809
4. Advanced research and technology development of antibody-drug conjugates Page:1810—1817
5. Advances in hyperprogressive disease of PD-1/PD-L1 antibody drugs and rational drug therapy Page:1735—1740
6. Non-coding RNA and tumor immune regulation Page:1783—1791
7. Research progress in immunotherapy for glioblastoma Page:1792—1801
8. The mechanism and research progress of drug resistance of PD-1/PD-L1 immunotherapy in tumors Page:1728—1734
9. Research progress of tumor immune and tumor metabolic drug targets Page:1718—1727
10. Review on clinical research progress of immunotherapy in liver cancer Page:1749—1754
11. Construction and anti-tumor efficacy of a peptide vaccine that targets calcium-binding protein S100A9 Page:1837—1844
12. Mechanistic advancement in chemotherapeutic agents modulated antitumor immune response Page:1741—1748
13. Research progress of dendritic cells anti-tumor vaccine stimulated by mRNA Page:1818—1823
14. The antitumor activity of STAT3 target inhibitor Bt354 andmolecular mechanism of anti-prostate cancer Page:1851—1857
15. The effects of different stimulators on the activation of human lymphocytes Page:1863—1867
16. Research advancement of succinyl-CoA transferase SCOT in tumor metabolism Page:1831—1836
17. DEPTOR improves cisplatin chemosensitivity in esophageal squamous cell carcinoma cells by inducing Caspase-1-mediated pyroptosis Page:1845—1850
18. Research progress of carnitine palmitoyltransferase 1in tumor immunotherapy Page:1824—1830
19. Post-translational modifications of proteins and cancer immunotherapy Page:1711—1717
20. Establishment and optimization of an enzyme-cell based high-throughput screening platform for IDO1 inhibitors Page:1868—1874
21. The optimization and application of cell-based screening model for IL-17-mediated signaling pathway Page:1858—1862
22. Establishment and application of STING agonist in-vitro screening model Page:1875—1880

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.